Literature DB >> 29144501

Novel mechanisms and functions of complement.

George Hajishengallis1, Edimara S Reis2, Dimitrios C Mastellos3, Daniel Ricklin4, John D Lambris2.   

Abstract

Progress at the beginning of the 21st century transformed the perception of complement from that of a blood-based antimicrobial system to that of a global regulator of immunity and tissue homeostasis. More recent years have witnessed remarkable advances in structure-function insights and understanding of the mechanisms and locations of complement activation, which have added new layers of complexity to the biology of complement. This complexity is readily reflected by the multifaceted and contextual involvement of complement-driven networks in a wide range of inflammatory and neurodegenerative disorders and cancer. This Review provides an updated view of new and previously unanticipated functions of complement and how these affect immunity and disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29144501      PMCID: PMC5706779          DOI: 10.1038/ni.3858

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  127 in total

Review 1.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 2.  Complement in the fundamental processes of the cell.

Authors:  Owen A Hawksworth; Liam G Coulthard; Trent M Woodruff
Journal:  Mol Immunol       Date:  2016-11-25       Impact factor: 4.407

3.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

4.  Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.

Authors:  Min Soon Cho; Rajesha Rupaimoole; Hyun-Jin Choi; Kyunghee Noh; Jichao Chen; Qianghua Hu; Anil K Sood; Vahid Afshar-Kharghan
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

5.  Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis.

Authors:  C Ning; Y-Y Li; Y Wang; G-C Han; R-X Wang; H Xiao; X-Y Li; C-M Hou; Y-F Ma; D-S Sheng; B-F Shen; J-N Feng; R-F Guo; Y Li; G-J Chen
Journal:  Mucosal Immunol       Date:  2015-03-04       Impact factor: 7.313

Review 6.  More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.

Authors:  George Hajishengallis; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 7.  Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.

Authors:  Dimitrios C Mastellos; Despina Yancopoulou; Petros Kokkinos; Markus Huber-Lang; George Hajishengallis; Ali R Biglarnia; Florea Lupu; Bo Nilsson; Antonio M Risitano; Daniel Ricklin; John D Lambris
Journal:  Eur J Clin Invest       Date:  2015-03-09       Impact factor: 4.686

8.  Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.

Authors:  Rahasson R Ager; Maria I Fonseca; Shu-Hui Chu; Sam D Sanderson; Stephen M Taylor; Trent M Woodruff; Andrea J Tenner
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

9.  Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

Authors:  Adrienne Boire; Yilong Zou; Jason Shieh; Danilo G Macalinao; Elena Pentsova; Joan Massagué
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 10.  Let's Tie the Knot: Marriage of Complement and Adaptive Immunity in Pathogen Evasion, for Better or Worse.

Authors:  Kaila M Bennett; Suzan H M Rooijakkers; Ronald D Gorham
Journal:  Front Microbiol       Date:  2017-01-31       Impact factor: 5.640

View more
  130 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  Early local activation of complement in aqueous humour of patients with age-related macular degeneration.

Authors:  L Altay; V Sitnilska; T Schick; G Widmer; G Duchateau-Nguyen; P Piraino; A Jayagopal; F M Drawnel; S Fauser
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

3.  Back to the future - non-canonical functions of complement.

Authors:  Claudia Kemper; Jörg Köhl
Journal:  Semin Immunol       Date:  2018-06       Impact factor: 11.130

4.  Safety profile after prolonged C3 inhibition.

Authors:  Edimara S Reis; Nadja Berger; Xin Wang; Sophia Koutsogiannaki; Robert K Doot; Justin T Gumas; Periklis G Foukas; Ranillo R G Resuello; Joel V Tuplano; David Kukis; Alice F Tarantal; Anthony J Young; Tetsuhiro Kajikawa; Athena M Soulika; Dimitrios C Mastellos; Despina Yancopoulou; Ali-Reza Biglarnia; Markus Huber-Lang; George Hajishengallis; Bo Nilsson; John D Lambris
Journal:  Clin Immunol       Date:  2018-10-10       Impact factor: 3.969

Review 5.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

6.  High complement levels in astrocyte-derived exosomes of Alzheimer disease.

Authors:  Edward J Goetzl; Janice B Schwartz; Erin L Abner; Gregory A Jicha; Dimitrios Kapogiannis
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

Review 7.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

8.  Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B.

Authors:  Xin Xu; Chi Zhang; Dalton T Denton; Daniel O'Connell; Daniel W Drolet; Brian V Geisbrecht
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

9.  Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.

Authors:  Nagihan Bostanci; Kai Bao; Xiaofei Li; Tomoki Maekawa; Jonas Grossmann; Christian Panse; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Cristina A G Garcia; Edimara S Reis; John D Lambris; George Hajishengallis
Journal:  J Proteome Res       Date:  2018-08-29       Impact factor: 4.466

10.  Identification of complement inhibitory activities of two chemotherapeutic agents using a high-throughput cell imaging-based screening assay.

Authors:  Lingjun Zhang; Yuriy Fedorov; Drew Adams; Feng Lin
Journal:  Mol Immunol       Date:  2018-06-15       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.